The Latest Liquidations: November 29, 2022
by Marlena Haddad on 2022-11-29 at 5:51pm

 


Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC Liquidations: Sandbridge X2 Corp., PWP Forward Acquisition Corp. I, Crucible Acquisition Corp., and Tishman Speyer Innovation Corp. II


Sandbridge X2 Corp. to Liquidate Trust

Sandbridge X2 Corp. (NYSE:SBII) disclosed in an 8-K this afternoon that shareholders have approved an amendment to allow the company to redeem all of its outstanding Class A common stock on or prior to December 15, 2022.

In connection with the meeting, holders of 21,611,237 outstanding shares exercised their right to redeem their shares for cash at a redemption price of approximately $10.09 per share, for an aggregate redemption amount of approximately $218,136,001.27. Following such redemptions, 2,206,464 shares remain outstanding and the company expects to redeem those shares at $10.09 as well.

READ

PWP Forward Acquisition Corp. I to Liquidate Trust

PWP Forward Acquisition Corp. I (NASDAQ:FRW) disclosed in an 8-K this afternoon that shareholders approved a proposal to change its termination date from March 12, 2023 to November 29, 2022 and liquidate its trust.
Holders of 20,971,675 shares exercised their right to redeem their shares for cash at a redemption price of approximately $10.07 per share, for an aggregate redemption amount of approximately $211,168,948.92. Following the redemptions, 191,758 shares remain outstanding.
READ

Crucible Acquisition Corp. to Liquidate Trust

Crucible Acquisition Corporation (NYSE:CRU) disclosed in an 8-K this afternoon that it held a special meeting of its stockholders at which the company’s stockholders approved amendments to dissolve and liquidate its trust.

The SPAC’s completion deadline was moved from January 7, 2023 to November 30, 2022. Holders of 24,243,057 shares exercised their right to redeem their shares for cash at a redemption price of approximately $10.09 per share, for an aggregate redemption amount of $244,554,766.56.

Following the redemptions, 1,631,943 shares remain outstanding will be redeemed for cash at a redemption price of approximately $10.03 per share, for an aggregate redemption amount of $16,362,422.20.

READ

Tishman Speyer Innovation Corp. II to Liquidate Trust

At the special meeting of the stockholders of Tishman Speyer Innovation Corp. II (NASDAQ:TSIB) held this afternoon, stockholders of the company approved an amendment to change the termination date from February 17, 2023 to November 30, 2022.

The company now expects to complete the mandatory redemption on or around December 2, 2022, at a per-share redemption price of approximately $10.00.

READ

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved